GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Krystal Biotech Inc (STU:4KB) » Definitions » Accumulated other comprehensive income (loss)

Krystal Biotech (STU:4KB) Accumulated other comprehensive income (loss) : €-0.28 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Krystal Biotech Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Krystal Biotech's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2024 was €-0.28 Mil.

Krystal Biotech's quarterly Accumulated other comprehensive income (loss) increased from Sep. 2023 (€-0.36 Mil) to Dec. 2023 (€0.59 Mil) but then declined from Dec. 2023 (€0.59 Mil) to Mar. 2024 (€-0.28 Mil).

Krystal Biotech's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 (€-0.14 Mil) to Dec. 2022 (€-0.69 Mil) but then increased from Dec. 2022 (€-0.69 Mil) to Dec. 2023 (€0.59 Mil).

Krystal Biotech Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Krystal Biotech's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Krystal Biotech Accumulated other comprehensive income (loss) Chart

Krystal Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial 0.01 0.01 -0.14 -0.69 0.59

Krystal Biotech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.14 -0.22 -0.36 0.59 -0.28

Krystal Biotech Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Krystal Biotech Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Krystal Biotech's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Krystal Biotech (STU:4KB) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Krystal Biotech Inc (STU:4KB) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
BPMC FOLD NUVL INSM CRSP CYTK IMGN TRML ACAD AXSM OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
KRYS:USA
Address
2100 Wharton Street, Suite 701, Pittsburgh, PA, USA, 15203
Website
https://www.krystalbio.com
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on development of easy to use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future.

Krystal Biotech (STU:4KB) Headlines

No Headlines